The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Meta-analysis of randomized control trials for the incidence and risk of treatment-related mortality in patients with cancer treated with vascular endothelial growth factor tyrosine kinase inhibitors.
Christopher J. Richards
No relevant relationships to disclose
Youjin Je
No relevant relationships to disclose
Fabio A. B. Schutz
No relevant relationships to disclose
Toni K. Choueiri
Consultant or Advisory Role - AVEO (U); GlaxoSmithKline (U); Novartis (U); Pfizer (U)